Literature DB >> 24202305

Circulating CD40+ and CD86+ B cell subsets demonstrate opposing associations with risk of stroke.

Polyxeni T Mantani1, Irena Ljungcrantz, Linda Andersson, Ragnar Alm, Bo Hedblad, Harry Björkbacka, Jan Nilsson, Gunilla Nordin Fredrikson.   

Abstract

OBJECTIVE: Accumulating evidence shows that immune cells play an important role in atherosclerosis. Most attention has focused on the role of different T cell subsets, whereas the possible involvement of B cells has been less studied. In this study, we assessed the association of 2 different B cell subsets, CD19(+)CD40(+) and CD19(+)CD86(+) B cells, with risk for development of acute cardiovascular events. APPROACH AND
RESULTS: The prospective study included 700 subjects randomly selected from the cardiovascular cohort of the Malmö Diet and Cancer study. Mononuclear leukocytes, stored at -140(○)C at the baseline investigation in 1991-1994, were thawed and B cell subsets analyzed by flow cytometry. Cytokine release from CD3/CD28-stimulated mononuclear leukocytes was measured with multiplex ELISA. Baseline carotid intima-media thickness and stenosis were assessed by ultrasonography, and clinical events were monitored through validated national registers during a median/mean follow-up time of 15 years. The subjects in the highest tertile of CD19(+)CD40(+) B cells had a significantly lower risk of incident stroke after adjustment for other risk factors. In contrast, CD19(+)CD86(+) B cells were associated with higher risk for development of a stroke event and increased release of proinflammatory cytokines from mononuclear leukocytes.
CONCLUSIONS: These observations provide evidence for an involvement of B cells in the incidence of stroke and suggest that both pathogenic and protective B cell subsets exist.

Entities:  

Keywords:  B-lymphocyte subsets; carotid artery diseases; prospective studies; stroke

Mesh:

Substances:

Year:  2013        PMID: 24202305     DOI: 10.1161/ATVBAHA.113.302667

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  17 in total

Review 1.  Lymphocytes in atherosclerosis.

Authors:  Catherine C Hedrick
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-02       Impact factor: 8.311

2.  Monocyte subsets, T cell activation profiles, and stroke in men and women: The Multi-Ethnic Study of Atherosclerosis and Cardiovascular Health Study.

Authors:  Matthew J Feinstein; Petra Buzkova; Nels C Olson; Margaret F Doyle; Colleen M Sitlani; Alison E Fohner; Sally A Huber; James Floyd; Arjun Sinha; Edward B Thorp; Alan Landay; Matthew S Freiberg; William T Longstreth; Russell P Tracy; Bruce M Psaty; Joseph Ac Delaney
Journal:  Atherosclerosis       Date:  2022-05-14       Impact factor: 6.847

Review 3.  Opportunities for an atherosclerosis vaccine: From mice to humans.

Authors:  Payel Roy; Amal J Ali; Kouji Kobiyama; Yanal Ghosheh; Klaus Ley
Journal:  Vaccine       Date:  2020-01-19       Impact factor: 3.641

4.  Innate and adaptive immune cell subsets as risk factors for coronary heart disease in two population-based cohorts.

Authors:  Nels C Olson; Colleen M Sitlani; Margaret F Doyle; Sally A Huber; Alan L Landay; Russell P Tracy; Bruce M Psaty; Joseph A Delaney
Journal:  Atherosclerosis       Date:  2020-03-16       Impact factor: 5.162

5.  Leukocyte response is regulated by microRNA let7i in patients with acute ischemic stroke.

Authors:  Glen C Jickling; Bradley P Ander; Natasha Shroff; Miles Orantia; Boryana Stamova; Cheryl Dykstra-Aiello; Heather Hull; Xinhua Zhan; DaZhi Liu; Frank R Sharp
Journal:  Neurology       Date:  2016-10-26       Impact factor: 9.910

Review 6.  Markers of inflammation associated with plaque progression and instability in patients with carotid atherosclerosis.

Authors:  Enrico Ammirati; Francesco Moroni; Giuseppe Danilo Norata; Marco Magnoni; Paolo G Camici
Journal:  Mediators Inflamm       Date:  2015-04-16       Impact factor: 4.711

7.  First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia.

Authors:  Frank C Barone; Deborah Gustafson; Howard A Crystal; Herman Moreno; Mateusz G Adamski; Ken Arai; Alison E Baird; Clotilde Balucani; Adam M Brickman; David Cechetto; Philip Gorelick; Geert Jan Biessels; Amanda Kiliaan; Lenore Launer; Julie Schneider; Farzaneh A Sorond; Rachel Whitmer; Clinton Wright; Zheng Gang Zhang
Journal:  J Transl Med       Date:  2016-02-13       Impact factor: 5.531

Review 8.  Anti-inflammatory and Immunomodulatory Therapies in Atherosclerosis.

Authors:  Justine Deroissart; Florentina Porsch; Thomas Koller; Christoph J Binder
Journal:  Handb Exp Pharmacol       Date:  2022

Review 9.  B Cells in Atherosclerosis: Mechanisms and Potential Clinical Applications.

Authors:  Tanyaporn Pattarabanjird; Cynthia Li; Coleen McNamara
Journal:  JACC Basic Transl Sci       Date:  2021-06-28

10.  High Levels of (Un)Switched Memory B Cells Are Associated With Better Outcome in Patients With Advanced Atherosclerotic Disease.

Authors:  John A L Meeuwsen; Amerik van Duijvenvoorde; Aisha Gohar; Maria O Kozma; Sander M van de Weg; Crystel M Gijsberts; Saskia Haitjema; Harry Björkbacka; Gunilla N Fredrikson; Gert J de Borst; Hester M den Ruijter; Gerard Pasterkamp; Christoph J Binder; Imo E Hoefer; Saskia C A de Jager
Journal:  J Am Heart Assoc       Date:  2017-09-07       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.